Skip to content

Mirabaud Asset Management (France) SAS

Follow

13F filer, CIK 2033031, PARIS, France

Mirabaud Asset Management (France) SAS reported $126,265,089 across 16 holdings for the quarter ended 2025-03-31, in a 13F-HR filed 2025-05-14. Its ten largest share positions make up 75.46% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0002033031-25-000005

Period
2025-03-31
Reported value
$126M
Holdings
16
Top 10 weight
75.46%
New
11
Sold out
4

Holdings, Q1 2025

Share positions as resolved from 13F-HR 0002033031-25-000005, largest first. % of portfolio is the value over $126,265,089, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline

Principal amounts

Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).

SecurityTypeAmountValueChange
ON SEMICONDUCTOR CORPON SEMICONDUCTOR CORP NOTE 5/0principal14,400,000$15.2Mnew
WAYFAIR INCWAYFAIR INC Convertible bondprincipal13,660,000$15.2Mnew
DATADOG INCDATADOG INC NOTE 0.125% 6/1principal13,000,000$14.8Mnew
RIVIAN AUTOMOTIVE INCRIVIAN AUTOMOTIVE INC NOTE 4.625% 3/1principal8,300,000$8.17Mnew
ENOVIS CORPORATIONENOVIS CORPORATION NOTE 3.875%10/1principal7,650,000$8Mnew
WORKIVA INCWORKIVA INC NOTE 1.250% 8/1principal8,200,000$7.8Mnew
SEAGATE HDD CAYMANSEAGATE HDD CAYMAN NOTE 3.500% 6/0principal6,400,000$7.74M-300,000
LUMENTUM HLDGS INCLUMENTUM HLDGS INC NOTE 1.500%12/1principal6,300,000$7.48Mnew
LIBERTY MEDIA CORP DELLIBERTY MEDIA CORP DEL NOTE 2.250% 8/1principal4,500,000$5.47Mnew
LIVE NATION ENTERTAINMENT INLIVE NATION ENTERTAINMENT IN NOTE 3.125% 1/1principal4,000,000$5.44Mnew
CYTOKINETICS INCCYTOKINETICS INC NOTE 3.500% 7/0principal4,500,000$5.36M0
NCL CORP LTDNCL CORP LTD NOTE 5.375% 8/0principal4,600,000$5.34Mnew
ZSCALER INCZSCALER INC NOTE 0.125% 7/0principal3,800,000$5.25Mnew
EQUINOX GOLD CORPEQUINOX GOLD CORP NOTE 4.750%10/1principal3,810,000$5.18M-11,010,000
ALNYLAM PHARMACEUTICALS INCALNYLAM PHARMACEUTICALS INC NOTE 1.000% 9/1principal4,300,000$4.96M-900,000
LI AUTO INCLI AUTO INC NOTE 0.250% 5/0principal4,100,000$4.89M-10,350,000

Sold out in Q1 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
RAPID7 INCRAPID7 INC12,100,000$11.7Mprincipal
HALOZYME THERAPEUTICS INCHALOZYME THERAPEUTICS INC7,950,000$8.63Mprincipal
AKAMAI TECHNOLOGIES INCAKAMAI TECHNOLOGIES INC7,500,000$7.99Mprincipal
WAYFAIR INCWAYFAIR INC5,100,000$5.51Mprincipal

How Q1 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0002033031-25-000005 base2025-05-14acceptance time not in the bulk data set